HEADER    TRANSCRIPTION                           31-OCT-16   5M96              
TITLE     SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW TRIAZOLO AND               
TITLE    2 IMIDAZOLOPYRIDINE RORGT INVERSE AGONISTS                             
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA;                                
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 FRAGMENT: C-TERMINAL DOMAIN, LIGAND BINDING DOMAIN, UNP RESIDUES 263-
COMPND   5 491;                                                                 
COMPND   6 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1     
COMPND   7 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED      
COMPND   8 ORPHAN RECEPTOR-GAMMA;                                               
COMPND   9 ENGINEERED: YES;                                                     
COMPND  10 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: RORC, NR1F3, RORG, RZRG;                                       
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21;                            
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 511693;                                     
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID                               
KEYWDS    NUCLEAR HORMONE RECEPTOR, LIGAND-BINDING DOMAIN, INVERSE AGONIST,     
KEYWDS   2 TRANSCRIPTION                                                        
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    J.KALLEN                                                              
REVDAT   4   08-MAY-24 5M96    1       REMARK                                   
REVDAT   3   19-DEC-18 5M96    1       REMARK LINK   SITE   ATOM                
REVDAT   2   28-DEC-16 5M96    1       JRNL                                     
REVDAT   1   14-DEC-16 5M96    0                                                
JRNL        AUTH   S.HINTERMANN,C.GUNTERMANN,H.MATTES,D.A.CARCACHE,J.WAGNER,    
JRNL        AUTH 2 A.VULPETTI,A.BILLICH,J.DAWSON,K.KAUPMANN,J.KALLEN,           
JRNL        AUTH 3 R.STRINGER,D.ORAIN                                           
JRNL        TITL   SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW TRIAZOLO- AND     
JRNL        TITL 2 IMIDAZOLOPYRIDINE ROR GAMMA T INVERSE AGONISTS.              
JRNL        REF    CHEMMEDCHEM                   V.  11  2640 2016              
JRNL        REFN                   ESSN 1860-7187                               
JRNL        PMID   27902884                                                     
JRNL        DOI    10.1002/CMDC.201600500                                       
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.77 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC                                               
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 19.28                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.9                           
REMARK   3   NUMBER OF REFLECTIONS             : 60571                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.193                           
REMARK   3   R VALUE            (WORKING SET) : 0.192                           
REMARK   3   FREE R VALUE                     : 0.208                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.000                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 3187                            
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 3662                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 140                                     
REMARK   3   SOLVENT ATOMS            : 349                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 34.60                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 28.53                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 0.00000                                              
REMARK   3    B22 (A**2) : 0.00000                                              
REMARK   3    B33 (A**2) : -0.01000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): 0.108         
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.099         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.066         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.062         
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   DISTANCE RESTRAINTS.                    RMS    SIGMA               
REMARK   3    BOND LENGTH                     (A) : NULL  ; NULL                
REMARK   3    ANGLE DISTANCE                  (A) : NULL  ; NULL                
REMARK   3    INTRAPLANAR 1-4 DISTANCE        (A) : NULL  ; NULL                
REMARK   3    H-BOND OR METAL COORDINATION    (A) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   PLANE RESTRAINT                  (A) : NULL  ; NULL                
REMARK   3   CHIRAL-CENTER RESTRAINT       (A**3) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   NON-BONDED CONTACT RESTRAINTS.                                     
REMARK   3    SINGLE TORSION                  (A) : NULL  ; NULL                
REMARK   3    MULTIPLE TORSION                (A) : NULL  ; NULL                
REMARK   3    H-BOND (X...Y)                  (A) : NULL  ; NULL                
REMARK   3    H-BOND (X-H...Y)                (A) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   CONFORMATIONAL TORSION ANGLE RESTRAINTS.                           
REMARK   3    SPECIFIED                 (DEGREES) : NULL  ; NULL                
REMARK   3    PLANAR                    (DEGREES) : NULL  ; NULL                
REMARK   3    STAGGERED                 (DEGREES) : NULL  ; NULL                
REMARK   3    TRANSVERSE                (DEGREES) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN    
REMARK   3  THE INPUT U VALUES : REFINED INDIVIDUALLY                           
REMARK   4                                                                      
REMARK   4 5M96 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-OCT-16.                  
REMARK 100 THE DEPOSITION ID IS D_1200002115.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 12-DEC-15                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 7.0                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : SLS                                
REMARK 200  BEAMLINE                       : X10SA                              
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.00003                            
REMARK 200  MONOCHROMATOR                  : SI 111 CHANNEL                     
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : PIXEL                              
REMARK 200  DETECTOR MANUFACTURER          : PSI PILATUS 6M                     
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XSCALE                             
REMARK 200  DATA SCALING SOFTWARE          : XSCALE, XSCALE                     
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 63761                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.770                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 19.870                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.9                               
REMARK 200  DATA REDUNDANCY                : 10.20                              
REMARK 200  R MERGE                    (I) : 0.05300                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 26.3000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.82                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 100.0                              
REMARK 200  DATA REDUNDANCY IN SHELL       : 10.20                              
REMARK 200  R MERGE FOR SHELL          (I) : 0.90300                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 2.800                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: PHASER                                                
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 60.52                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.75M NAFORMATE, 0.1M PIPES, PH 7.0,     
REMARK 280  VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61                             
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -Y,X-Y,Z+1/3                                            
REMARK 290       3555   -X+Y,-X,Z+2/3                                           
REMARK 290       4555   -X,-Y,Z+1/2                                             
REMARK 290       5555   Y,-X+Y,Z+5/6                                            
REMARK 290       6555   X-Y,X,Z+1/6                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       38.56200            
REMARK 290   SMTRY1   3 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   3 -0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000       77.12400            
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   4  0.000000  0.000000  1.000000       57.84300            
REMARK 290   SMTRY1   5  0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   5 -0.866025  0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   5  0.000000  0.000000  1.000000       96.40500            
REMARK 290   SMTRY1   6  0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   6  0.866025  0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   6  0.000000  0.000000  1.000000       19.28100            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2                                                    
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     GLY A   262                                                      
REMARK 465     PRO A   263                                                      
REMARK 465     TYR A   264                                                      
REMARK 465     HIS A   490                                                      
REMARK 465     PRO A   491                                                      
REMARK 465     GLY B   262                                                      
REMARK 465     PRO B   263                                                      
REMARK 465     TYR B   264                                                      
REMARK 465     HIS B   488                                                      
REMARK 465     LEU B   489                                                      
REMARK 465     HIS B   490                                                      
REMARK 465     PRO B   491                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    GLU A 435       62.65   -115.30                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y A 501                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y A 502                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y B 501                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC4                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y B 502                 
DBREF  5M96 A  263   491  UNP    P51449   RORG_HUMAN     263    491             
DBREF  5M96 B  263   491  UNP    P51449   RORG_HUMAN     263    491             
SEQADV 5M96 GLY A  262  UNP  P51449              EXPRESSION TAG                 
SEQADV 5M96 SER A  455  UNP  P51449    CYS   455 ENGINEERED MUTATION            
SEQADV 5M96 GLY B  262  UNP  P51449              EXPRESSION TAG                 
SEQADV 5M96 SER B  455  UNP  P51449    CYS   455 ENGINEERED MUTATION            
SEQRES   1 A  230  GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL          
SEQRES   2 A  230  GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU          
SEQRES   3 A  230  ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE          
SEQRES   4 A  230  SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET          
SEQRES   5 A  230  TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU          
SEQRES   6 A  230  ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER          
SEQRES   7 A  230  GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU          
SEQRES   8 A  230  LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET          
SEQRES   9 A  230  CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE          
SEQRES  10 A  230  GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU          
SEQRES  11 A  230  GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER          
SEQRES  12 A  230  HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE          
SEQRES  13 A  230  ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG          
SEQRES  14 A  230  PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN          
SEQRES  15 A  230  TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS          
SEQRES  16 A  230  THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS          
SEQRES  17 A  230  GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG          
SEQRES  18 A  230  LEU GLN ILE PHE GLN HIS LEU HIS PRO                          
SEQRES   1 B  230  GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL          
SEQRES   2 B  230  GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU          
SEQRES   3 B  230  ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE          
SEQRES   4 B  230  SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET          
SEQRES   5 B  230  TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU          
SEQRES   6 B  230  ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER          
SEQRES   7 B  230  GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU          
SEQRES   8 B  230  LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET          
SEQRES   9 B  230  CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE          
SEQRES  10 B  230  GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU          
SEQRES  11 B  230  GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER          
SEQRES  12 B  230  HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE          
SEQRES  13 B  230  ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG          
SEQRES  14 B  230  PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN          
SEQRES  15 B  230  TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS          
SEQRES  16 B  230  THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS          
SEQRES  17 B  230  GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG          
SEQRES  18 B  230  LEU GLN ILE PHE GLN HIS LEU HIS PRO                          
HET    Q6Y  A 501      35                                                       
HET    Q6Y  A 502      35                                                       
HET    Q6Y  B 501      35                                                       
HET    Q6Y  B 502      35                                                       
HETNAM     Q6Y ~{N}-[8-[[(3~{S})-4-CYCLOPENTYLCARBONYL-3-METHYL-                
HETNAM   2 Q6Y  PIPERAZIN-1-YL]METHYL]-7-METHYL-IMIDAZO[1,2-A]PYRIDIN-          
HETNAM   3 Q6Y  6-YL]-2-METHYL-PYRIMIDINE-5-CARBOXAMIDE                         
FORMUL   3  Q6Y    4(C26 H33 N7 O2)                                             
FORMUL   7  HOH   *349(H2 O)                                                    
HELIX    1 AA1 SER A  266  GLU A  283  1                                  18    
HELIX    2 AA2 ARG A  288  GLN A  295  1                                   8    
HELIX    3 AA3 ARG A  296  ASN A  298  5                                   3    
HELIX    4 AA4 SER A  301  LYS A  311  1                                  11    
HELIX    5 AA5 SER A  312  LEU A  338  1                                  27    
HELIX    6 AA6 GLY A  340  LEU A  344  5                                   5    
HELIX    7 AA7 CYS A  345  MET A  365  1                                  21    
HELIX    8 AA8 GLY A  384  GLY A  392  5                                   9    
HELIX    9 AA9 CYS A  393  ALA A  409  1                                  17    
HELIX   10 AB1 SER A  413  ILE A  426  1                                  14    
HELIX   11 AB2 GLU A  435  THR A  457  1                                  23    
HELIX   12 AB3 ARG A  459  LEU A  466  5                                   8    
HELIX   13 AB4 PRO A  468  LEU A  489  1                                  22    
HELIX   14 AB5 SER B  266  THR B  284  1                                  19    
HELIX   15 AB6 ARG B  288  GLN B  295  1                                   8    
HELIX   16 AB7 ARG B  296  ASN B  298  5                                   3    
HELIX   17 AB8 SER B  301  LYS B  311  1                                  11    
HELIX   18 AB9 SER B  312  ARG B  337  1                                  26    
HELIX   19 AC1 LEU B  338  GLU B  343  1                                   6    
HELIX   20 AC2 CYS B  345  MET B  365  1                                  21    
HELIX   21 AC3 GLY B  384  GLY B  392  5                                   9    
HELIX   22 AC4 CYS B  393  LEU B  410  1                                  18    
HELIX   23 AC5 SER B  413  ILE B  426  1                                  14    
HELIX   24 AC6 GLU B  435  THR B  457  1                                  23    
HELIX   25 AC7 ARG B  459  LEU B  466  5                                   8    
HELIX   26 AC8 GLY B  470  GLN B  487  1                                  18    
SHEET    1 AA1 3 TYR A 369  ASN A 370  0                                        
SHEET    2 AA1 3 THR A 375  PHE A 378 -1  O  THR A 375   N  ASN A 370           
SHEET    3 AA1 3 LYS A 381  GLY A 383 -1  O  GLY A 383   N  VAL A 376           
SHEET    1 AA2 3 TYR B 369  ASN B 370  0                                        
SHEET    2 AA2 3 THR B 375  PHE B 378 -1  O  THR B 375   N  ASN B 370           
SHEET    3 AA2 3 LYS B 381  GLY B 383 -1  O  LYS B 381   N  PHE B 378           
SITE     1 AC1 16 CYS A 320  HIS A 323  LEU A 324  MET A 365                    
SITE     2 AC1 16 ALA A 368  VAL A 376  PHE A 377  PHE A 378                    
SITE     3 AC1 16 ILE A 400  PHE A 401  SER A 404  HIS A 479                    
SITE     4 AC1 16 PHE A 486  HOH A 653  HOH A 708  HOH A 711                    
SITE     1 AC2 12 THR A 325  ILE A 328  GLN A 329  GLU A 333                    
SITE     2 AC2 12 LYS A 354  MET A 358  HOH A 657  GLN B 346                    
SITE     3 AC2 12 ILE B 350  LEU B 353  Q6Y B 502  HOH B 663                    
SITE     1 AC3 16 CYS B 320  HIS B 323  LEU B 324  MET B 365                    
SITE     2 AC3 16 ALA B 368  VAL B 376  PHE B 377  LEU B 396                    
SITE     3 AC3 16 ILE B 397  ILE B 400  PHE B 401  SER B 404                    
SITE     4 AC3 16 HIS B 479  HOH B 629  HOH B 686  HOH B 689                    
SITE     1 AC4 11 THR A 325  ILE A 328  GLN A 329  VAL A 332                    
SITE     2 AC4 11 LEU A 353  Q6Y A 502  HOH A 657  VAL B 332                    
SITE     3 AC4 11 GLN B 346  ILE B 350  LYS B 354                               
CRYST1  100.017  100.017  115.686  90.00  90.00 120.00 P 61         12          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.009998  0.005773  0.000000        0.00000                         
SCALE2      0.000000  0.011545  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.008644        0.00000